Product Description
Melanocortin Receptor Agonist Research Peptide
PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist primarily studied for its activity on the MC4R pathway, which is involved in sexual desire, autonomic arousal, and neuroendocrine signaling.
It is frequently explored in research related to libido modulation, central melanocortin pathways, neurobehavioral responses, and mechanisms affecting sexual motivation and arousal in controlled experimental settings.
Key Research Areas
🧬
MC4R pathway activity and melanocortin receptor signaling research
🧠
Central melanocortin pathways in controlled laboratory models
⚡
Autonomic arousal and neuroendocrine signaling investigations
📊
Sexual motivation, libido modulation, and neurobehavioral response research models
This compound is frequently employed in advanced melanocortin and neurobehavioral pathway research supporting investigation of sexual motivation, receptor signaling, and autonomic response dynamics within laboratory environments.
Intended Use
📦 Format: Lyophilized powder (10mg)
⚠️ Use: For laboratory research use only. Not for human or veterinary use.
Why Researchers Choose This Compound
🔗
Targeted MC4R relevance supports focused receptor-pathway research without broader multi-compound complexity.
🧪
Broad neurobehavioral research utility makes it useful for central melanocortin, libido-modulation, and arousal-response investigations.
📈
Strong lab-validation value with COA and endotoxin documentation supporting controlled experimental workflows.
Product Notes
✅ Research category: Melanocortin and neuroendocrine signaling
✅ Study context: Laboratory and controlled experimental models
✅ Compound focus: MC4R activity, libido modulation, and arousal-related pathway analysis